Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2025 Filed May 19, 2025 20:45 UTC |
Hipple Richard JDirector
|
GrantDeferred Shares · Derivative | 8,798 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000075 · wk-form4_1747687494.xml · derivative · entry 2 Hipple Richard J · CIK 0001311365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,905 Underlying: Common Shares · 8,798 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share. F3 · price: The Deferred Shares were awarded under the Deferred Share Plan. F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028. F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:43 UTC |
Highsmith Carlton LDirector
|
GrantDeferred Shares · Derivative | 8,798 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000074 · wk-form4_1747687399.xml · derivative · entry 2 Highsmith Carlton L · CIK 0001379848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,905 Underlying: Common Shares · 8,798 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share. F3 · price: The Deferred Shares were awarded under the Deferred Share Plan. F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028. F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:42 UTC |
Hayes RobinDirector
|
GrantDeferred Shares · Derivative | 8,798 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000073 · wk-form4_1747687326.xml · derivative · entry 2 Hayes Robin · CIK 0001443147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,627 Underlying: Common Shares · 8,798 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share. F3 · price: The Deferred Shares were awarded under the Deferred Share Plan. F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028. F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:32 UTC |
Gile Elizabeth R.Director
|
GrantDeferred Shares · Derivative | 8,798 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000071 · wk-form4_1747686727.xml · derivative · entry 2 Gile Elizabeth R. · CIK 0001487311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,443 Underlying: Common Shares · 8,798 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share. F3 · price: The Deferred Shares were awarded under the Deferred Share Plan. F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until July 1, 2030. F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until July 1, 2030. F4 · balance_after: Includes approximately 1,480 dividend-equivalent Deferred Shares accrued in March 2025. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:30 UTC |
Dallas H JamesDirector
|
GrantDeferred Shares · Derivative | 8,798 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000070 · wk-form4_1747686637.xml · derivative · entry 2 Dallas H James · CIK 0001324953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,905 Underlying: Common Shares · 8,798 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share. F3 · price: The Deferred Shares were awarded under the Deferred Share Plan. F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028. F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 15, 2028. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:28 UTC |
CUTLER ALEXANDER MDirector
|
GrantDeferred Shares · Derivative | 8,798 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000069 · wk-form4_1747686507.xml · derivative · entry 2 CUTLER ALEXANDER M · CIK 0001188585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,795 Underlying: Common Shares · 8,798 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share. F3 · price: The Deferred Shares were awarded under the Deferred Share Plan. F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until July 1, 2028. F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until July 1, 2028. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:27 UTC |
Allard JacquiDirector
|
GrantDeferred Shares · Derivative | 8,798 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000068 · wk-form4_1747686422.xml · derivative · entry 2 Allard Jacqui · CIK 0002050454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,798 Underlying: Common Shares · 8,798 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share is the economic equivalent of one Common Share. F3 · price: The Deferred Shares were awarded under the Deferred Share Plan. F2 · derivative.exercise_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until October 1, 2029. F2 · derivative.expiration_date: Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"), payment of the deferred shares has been deferred until October 1, 2029. Read SEC document |
| May 13, 2025 Filed May 14, 2025 21:04 UTC |
Highsmith Carlton LDirector
|
SaleCommon Shares | 5,000 | $16.60 | $83,000.00 |
DisclosureSEC source: 0000091576-25-000065 · wk-form4_1747256664.xml · nonDerivative · entry 3 Highsmith Carlton L · CIK 0001379848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,177 Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:07 UTC |
Hipple Richard JDirector
|
Exercise / conversionDeferred Shares · Derivative | 8,626 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000091576-25-000066 · wk-form4_1747256867.xml · derivative · entry 3 Hipple Richard J · CIK 0001311365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,107 Underlying: Common Shares · 8,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · derivative.exercise_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · derivative.expiration_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F3 · balance_after: Includes approximately 1,815 dividend-equivalent Deferred Shares accrued between June 2024 and March 2025. Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:07 UTC |
Hipple Richard JDirector
|
Disposition to issuerCommon Shares | 4,312 | $14.70 | $63,386.40 |
DisclosureSEC source: 0000091576-25-000066 · wk-form4_1747256867.xml · nonDerivative · entry 2 Hipple Richard J · CIK 0001311365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,420 Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:07 UTC |
Hipple Richard JDirector
|
Exercise / conversionCommon Shares | 8,626 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000091576-25-000066 · wk-form4_1747256867.xml · nonDerivative · entry 1 Hipple Richard J · CIK 0001311365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F2 · balance_after: Includes approximately 1,628 common shares acquired through dividend reinvestments between June 2024 and March 2025. Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:04 UTC |
Highsmith Carlton LDirector
|
Exercise / conversionDeferred Shares · Derivative | 8,626 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000091576-25-000065 · wk-form4_1747256664.xml · derivative · entry 4 Highsmith Carlton L · CIK 0001379848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,107 Underlying: Common Shares · 8,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · derivative.exercise_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · derivative.expiration_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F2 · balance_after: Includes approximately 1,815 dividend-equivalent Deferred Shares accrued between June 2024 and March 2025. Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:04 UTC |
Highsmith Carlton LDirector
|
Disposition to issuerCommon Shares | 4,312 | $14.70 | $63,386.40 |
DisclosureSEC source: 0000091576-25-000065 · wk-form4_1747256664.xml · nonDerivative · entry 2 Highsmith Carlton L · CIK 0001379848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,178 Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:04 UTC |
Highsmith Carlton LDirector
|
Exercise / conversionCommon Shares | 8,626 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000091576-25-000065 · wk-form4_1747256664.xml · nonDerivative · entry 1 Highsmith Carlton L · CIK 0001379848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:03 UTC |
Hayes RobinDirector
|
Exercise / conversionDeferred Shares · Derivative | 8,626 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000091576-25-000064 · wk-form4_1747256574.xml · derivative · entry 3 Hayes Robin · CIK 0001443147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,829 Underlying: Common Shares · 8,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · derivative.exercise_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · derivative.expiration_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:03 UTC |
Hayes RobinDirector
|
Disposition to issuerCommon Shares | 4,312 | $14.70 | $63,386.40 |
DisclosureSEC source: 0000091576-25-000064 · wk-form4_1747256574.xml · nonDerivative · entry 2 Hayes Robin · CIK 0001443147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,549 Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:03 UTC |
Hayes RobinDirector
|
Exercise / conversionCommon Shares | 8,626 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000091576-25-000064 · wk-form4_1747256574.xml · nonDerivative · entry 1 Hayes Robin · CIK 0001443147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:01 UTC |
Dallas H JamesDirector
|
Exercise / conversionDeferred Shares · Derivative | 8,626 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000091576-25-000063 · wk-form4_1747256475.xml · derivative · entry 3 Dallas H James · CIK 0001324953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,107 Underlying: Common Shares · 8,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · derivative.exercise_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F1 · derivative.expiration_date: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. F2 · balance_after: Includes approximately 1,815 dividend-equivalent Deferred Shares accrued between June 2024 and March 2025. Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:01 UTC |
Dallas H JamesDirector
|
Disposition to issuerCommon Shares | 4,312 | $14.70 | $63,386.40 |
DisclosureSEC source: 0000091576-25-000063 · wk-form4_1747256475.xml · nonDerivative · entry 2 Dallas H James · CIK 0001324953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,710 Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:01 UTC |
Dallas H JamesDirector
|
Exercise / conversionCommon Shares | 8,626 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000091576-25-000063 · wk-form4_1747256475.xml · nonDerivative · entry 1 Dallas H James · CIK 0001324953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Share was the economic equivalent of one KeyCorp Common Share. On May 12, 2025, 4,312 of the Reporting Person's Deferred Shares were settled for cash based upon the average of the closing price of KeyCorp Common Shares over the 30 trading days immediately prior to (and including if such date is a trading day) the payment date, and the remaining 4,314 Deferred Shares were settled for an equal number of KeyCorp Common Shares. Read SEC document |
| April 22, 2025 Filed Apr 23, 2025 21:21 UTC |
Allard JacquiDirector
|
PurchaseCommon Shares | 180 | $14.03 | $2,525.40 |
DisclosureSEC source: 0000091576-25-000054 · wk-form4_1745443289.xml · nonDerivative · entry 1 Allard Jacqui · CIK 0002050454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180 Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 21:19 UTC |
Tobin Richard JDirector
|
PurchaseCommon Shares | 750 | $13.84 | $10,380.00 |
DisclosureSEC source: 0000091576-25-000053 · wk-form4_1745443148.xml · nonDerivative · entry 1 Tobin Richard J · CIK 0001681915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750 Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 21:17 UTC |
Khanna SomeshDirector
|
PurchaseCommon Shares | 100 | $13.87 | $1,387.00 |
DisclosureSEC source: 0000091576-25-000052 · wk-form4_1745443032.xml · nonDerivative · entry 1 Khanna Somesh · CIK 0002050456 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100 Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 21:15 UTC |
Ramani MohitChief Risk Officer
|
PurchaseCommon Shares | 10,000 | $13.75 | $137,500.00 |
DisclosureSEC source: 0000091576-25-000051 · wk-form4_1745442933.xml · nonDerivative · entry 1 Ramani Mohit · CIK 0002053125 · Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.75 to $13.76. F2 · price: The reporting person may provide to KeyCorp, any security holder of KeyCorp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:33 UTC |
Tobin Richard JDirector
|
GrantDeferred Shares · Derivative | 1,876 | $15.99 | $29,997.24 |
DisclosureSEC source: 0000091576-25-000047 · wk-form4_1743626029.xml · derivative · entry 2 Tobin Richard J · CIK 0001681915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,695 Underlying: Common Shares · 1,876 shares Expires not disclosed F1 · derivative.exercise_price: Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares. F2 · derivative.exercise_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2027, or the death of the participant. F2 · derivative.expiration_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2027, or the death of the participant. F3 · balance_after: On October 2, 2024, the Reporting Person filed a Form 4 which inadvertently omitted the acquisition of 224 additional Deferred Shares. These additional Deferred Shares, acquired on September 30, 2024, are included in the total reported in this Form 4. F4 · balance_after: Includes approximately 765 dividend-equivalent deferred shares accrued under the Deferred Share Plan between December 2024 and March 2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:32 UTC |
VASOS TODD JDirector
|
GrantDeferred Shares · Derivative | 2,032 | $15.99 | $32,491.68 |
DisclosureSEC source: 0000091576-25-000046 · wk-form4_1743625913.xml · derivative · entry 2 VASOS TODD J · CIK 0001243183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,666 Underlying: Common Shares · 2,032 shares Expires not disclosed F1 · derivative.exercise_price: Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares. F2 · derivative.exercise_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2027, or the death of the participant. F2 · derivative.expiration_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2027, or the death of the participant. F3 · balance_after: Includes approximately 731 dividend-equivalent deferred shares accrued under the Deferred Share Plan in March 2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:24 UTC |
Rankin Devina ADirector
|
GrantDeferred Shares · Derivative | 1,876 | $15.99 | $29,997.24 |
DisclosureSEC source: 0000091576-25-000045 · wk-form4_1743625492.xml · derivative · entry 2 Rankin Devina A · CIK 0001557267 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,239 Underlying: Common Shares · 1,876 shares Expires not disclosed F1 · derivative.exercise_price: Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares. F2 · derivative.exercise_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2031, or the death of the participant. F2 · derivative.expiration_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2031, or the death of the participant. F3 · balance_after: Includes approximately 792 dividend-equivalent deferred shares accrued under the Deferred Share Plan in March 2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:22 UTC |
Hayes RobinDirector
|
GrantDeferred Shares · Derivative | 1,876 | $15.99 | $29,997.24 |
DisclosureSEC source: 0000091576-25-000044 · wk-form4_1743625345.xml · derivative · entry 2 Hayes Robin · CIK 0001443147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,455 Underlying: Common Shares · 1,876 shares Expires not disclosed F1 · derivative.exercise_price: Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares. F2 · derivative.exercise_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2028, or the death of the participant. F2 · derivative.expiration_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2028, or the death of the participant. F3 · balance_after: Includes approximately 704 dividend-equivalent deferred shares accrued under the Deferred Share Plan in March 2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:20 UTC |
CUTLER ALEXANDER MDirector
|
GrantDeferred Shares · Derivative | 1,407 | $15.99 | $22,497.93 |
DisclosureSEC source: 0000091576-25-000043 · wk-form4_1743625235.xml · derivative · entry 2 CUTLER ALEXANDER M · CIK 0001188585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,997 Underlying: Common Shares · 1,407 shares Expires not disclosed F1 · derivative.exercise_price: Directors may elect to defer the payment of directors' fees into the Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares. F2 · derivative.exercise_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of July 1, 2028, or the death of the participant. F2 · derivative.expiration_date: Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of July 1, 2028, or the death of the participant. F3 · balance_after: Includes approximately 705 dividend-equivalent deferred shares accrued under the Deferred Share Plan in March 2025. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:32 UTC |
Gorman Christopher M.Director · Chairman and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 39,352 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · derivative · entry 11 Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,054 Underlying: Common Shares · 39,352 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F13 · derivative.exercise_date: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025. F13 · derivative.expiration_date: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025. F14 · balance_after: Includes approximately 8,154 dividend-equivalent restricted stock units accrued between March and December 2024. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:32 UTC |
Gorman Christopher M.Director · Chairman and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 30,978 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · derivative · entry 10 Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,955 Underlying: Common Shares · 30,978 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F11 · derivative.exercise_date: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024. F11 · derivative.expiration_date: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024. F12 · balance_after: Includes approximately 4,814 dividend-equivalent restricted stock units accrued between March and December 2024. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:32 UTC |
Gorman Christopher M.Director · Chairman and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 24,558 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · derivative · entry 9 Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,558 Underlying: Common Shares · 24,558 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F9 · derivative.exercise_date: These restricted stock units, granted on February 14, 2022, vest in four equal annual installments beginning on February 17, 2023. F9 · derivative.expiration_date: These restricted stock units, granted on February 14, 2022, vest in four equal annual installments beginning on February 17, 2023. F10 · balance_after: Includes approximately 2,544 dividend-equivalent restricted stock units accrued between March and December 2024. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:32 UTC |
Gorman Christopher M.Director · Chairman and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 20,626 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · derivative · entry 8 Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 20,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F7 · derivative.exercise_date: These restricted stock units, granted on February 15, 2021, vest in four equal annual installments beginning on February 17, 2022. F7 · derivative.expiration_date: These restricted stock units, granted on February 15, 2021, vest in four equal annual installments beginning on February 17, 2022. F8 · derivative.underlying_shares: Includes approximately 1,068 dividend-equivalent restricted stock units accrued between March and December 2024. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:32 UTC |
Gorman Christopher M.Director · Chairman and CEO
|
GrantOption to Buy · Derivative | 139,959 | $0.00 Strike: $19.49 | $0.00 |
DisclosureSEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · derivative · entry 7 Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,959 Underlying: Common Shares · 139,959 shares Expires 2035-02-17 F6 · derivative.exercise_date: The option to buy, granted on February 17, 2025, vests in four equal annual installments beginning on February 17, 2026. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:32 UTC |
Gorman Christopher M.Director · Chairman and CEO
|
GrantRestricted Stock Units · Derivative | 116,817 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · derivative · entry 6 Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,817 Underlying: Common Shares · 116,817 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F5 · derivative.exercise_date: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026. F5 · derivative.expiration_date: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:32 UTC |
Gorman Christopher M.Director · Chairman and CEO
|
Tax withholdingCommon Shares | 45,559 | $17.72 | $807,305.48 |
DisclosureSEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · nonDerivative · entry 2 Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 869,721 Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:32 UTC |
Gorman Christopher M.Director · Chairman and CEO
|
Exercise / conversionCommon Shares | 115,514 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000091576-25-000032 · wk-form4_1740000743.xml · nonDerivative · entry 1 Gorman Christopher M. · CIK 0001486643 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 915,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F2 · balance_after: Includes approximately 463 common shares acquired under the KeyCorp Second Amended and Restated Discounted Stock Purchase Plan since March 2024. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:29 UTC |
Khayat Clark HChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,433 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · derivative · entry 8 Khayat Clark H · CIK 0001342543 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,296 Underlying: Common Shares · 8,433 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F10 · derivative.exercise_date: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025. F10 · derivative.expiration_date: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025. F11 · balance_after: Includes approximately 1,747 dividend-equivalent restricted stock units accrued between March and December 2024. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:29 UTC |
Khayat Clark HChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,311 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · derivative · entry 7 Khayat Clark H · CIK 0001342543 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,619 Underlying: Common Shares · 5,311 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F8 · derivative.exercise_date: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024. F8 · derivative.expiration_date: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024. F9 · balance_after: Includes approximately 825 dividend-equivalent restricted stock units accrued between March and December 2024. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:29 UTC |
Khayat Clark HChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,410 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · derivative · entry 6 Khayat Clark H · CIK 0001342543 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,410 Underlying: Common Shares · 3,410 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F6 · derivative.exercise_date: These restricted stock units, granted on February 14, 2022, vest in four equal annual installments beginning on February 17, 2023. F6 · derivative.expiration_date: These restricted stock units, granted on February 14, 2022, vest in four equal annual installments beginning on February 17, 2023. F7 · balance_after: Includes approximately 353 dividend-equivalent restricted stock units accrued between March and December 2024. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:29 UTC |
Khayat Clark HChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,316 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · derivative · entry 5 Khayat Clark H · CIK 0001342543 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 4,316 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F4 · derivative.exercise_date: These restricted stock units, granted on February 15, 2021, vest in four equal annual installments. The final installment vested on February 17, 2025. F4 · derivative.expiration_date: These restricted stock units, granted on February 15, 2021, vest in four equal annual installments. The final installment vested on February 17, 2025. F5 · derivative.underlying_shares: Includes approximately 224 dividend-equivalent restricted stock units accrued between March and December 2024. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:29 UTC |
Khayat Clark HChief Financial Officer
|
GrantOption to Buy · Derivative | 40,567 | $0.00 Strike: $19.49 | $0.00 |
DisclosureSEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · derivative · entry 4 Khayat Clark H · CIK 0001342543 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,567 Underlying: Common Shares · 40,567 shares Expires 2035-02-17 F3 · derivative.exercise_date: The option to buy, granted on February 17, 2025, vests in four equal annual installments beginning on February 17, 2026. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:29 UTC |
Khayat Clark HChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 33,860 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · derivative · entry 3 Khayat Clark H · CIK 0001342543 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,860 Underlying: Common Shares · 33,860 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F2 · derivative.exercise_date: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026. F2 · derivative.expiration_date: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:29 UTC |
Khayat Clark HChief Financial Officer
|
Tax withholdingCommon Shares | 6,758 | $17.72 | $119,751.76 |
DisclosureSEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · nonDerivative · entry 2 Khayat Clark H · CIK 0001342543 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,344 Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:29 UTC |
Khayat Clark HChief Financial Officer
|
Exercise / conversionCommon Shares | 21,470 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000091576-25-000030 · wk-form4_1740000544.xml · nonDerivative · entry 1 Khayat Clark H · CIK 0001342543 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:30 UTC |
Ramani MohitChief Risk Officer
|
GrantOption to Buy · Derivative | 26,369 | $0.00 Strike: $19.49 | $0.00 |
DisclosureSEC source: 0000091576-25-000031 · wk-form4_1740000633.xml · derivative · entry 3 Ramani Mohit · CIK 0002053125 · Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,369 Underlying: Common Shares · 26,369 shares Expires 2035-02-17 F3 · derivative.exercise_date: The option to buy, granted on February 17, 2025, vests in four equal annual installments beginning on February 17, 2026. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:30 UTC |
Ramani MohitChief Risk Officer
|
GrantRestricted Stock Units · Derivative | 22,009 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000031 · wk-form4_1740000633.xml · derivative · entry 2 Ramani Mohit · CIK 0002053125 · Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,009 Underlying: Common Shares · 22,009 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F2 · derivative.exercise_date: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026. F2 · derivative.expiration_date: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:26 UTC |
Gilbert Stacy LChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,406 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000029 · wk-form4_1740000392.xml · derivative · entry 8 Gilbert Stacy L · CIK 0002015919 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,215 Underlying: Common Shares · 1,406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F10 · derivative.exercise_date: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025. F10 · derivative.expiration_date: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025. F11 · balance_after: Includes approximately 216 dividend-equivalent restricted stock units accrued between June and December 2024. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:26 UTC |
Gilbert Stacy LChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 753 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000029 · wk-form4_1740000392.xml · derivative · entry 7 Gilbert Stacy L · CIK 0002015919 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,504 Underlying: Common Shares · 753 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F8 · derivative.exercise_date: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024. F8 · derivative.expiration_date: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024. F9 · balance_after: Includes approximately 87 dividend-equivalent restricted stock units accrued between June and December 2024. Read SEC document |
| February 17, 2025 Filed Feb 19, 2025 21:26 UTC |
Gilbert Stacy LChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 443 | $0.00 | $0.00 |
DisclosureSEC source: 0000091576-25-000029 · wk-form4_1740000392.xml · derivative · entry 6 Gilbert Stacy L · CIK 0002015919 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443 Underlying: Common Shares · 443 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F6 · derivative.exercise_date: These restricted stock units, granted on February 14, 2022, vest in four equal annual installments beginning on February 17, 2023. F6 · derivative.expiration_date: These restricted stock units, granted on February 14, 2022, vest in four equal annual installments beginning on February 17, 2023. F7 · balance_after: Includes approximately 34 dividend-equivalent restricted stock units accrued between June and December 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.